摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,2'-(((3,5-bis(trifluoromethyl)phenyl)(hydroxy)methylene)bis(1H-1,2,3-triazole-4,1-diyl))bis(4-chlorophenol)

中文名称
——
中文别名
——
英文名称
2,2'-(((3,5-bis(trifluoromethyl)phenyl)(hydroxy)methylene)bis(1H-1,2,3-triazole-4,1-diyl))bis(4-chlorophenol)
英文别名
2-[4-[[3,5-Bis(trifluoromethyl)phenyl]-[1-(5-chloro-2-hydroxyphenyl)triazol-4-yl]-hydroxymethyl]triazol-1-yl]-4-chlorophenol;2-[4-[[3,5-bis(trifluoromethyl)phenyl]-[1-(5-chloro-2-hydroxyphenyl)triazol-4-yl]-hydroxymethyl]triazol-1-yl]-4-chlorophenol
2,2'-(((3,5-bis(trifluoromethyl)phenyl)(hydroxy)methylene)bis(1H-1,2,3-triazole-4,1-diyl))bis(4-chlorophenol)化学式
CAS
——
化学式
C25H14Cl2F6N6O3
mdl
——
分子量
631.321
InChiKey
YZWBCCGVNPPQCA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    42
  • 可旋转键数:
    5
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    122
  • 氢给体数:
    3
  • 氢受体数:
    13

反应信息

点击查看最新优质反应信息

文献信息

  • SMALL MOLECULE INHIBITORS OF PI3-KINASE SIGNALING
    申请人:TUFTS UNIVERSITY
    公开号:US20160297777A1
    公开(公告)日:2016-10-13
    Provided are certain 1,2,3-triazole and 1,2,3-triazole dimer analogs of DM-PIT-1 which are second-generation selective non-phosphoinositide small molecule inhibitors of phosphatidylinositol-3,4,5-trisphosphate (PIP3), including 1,2,3-triazoles represented by formula (I) where: Ar represents aryl or heteroaryl; X represents O or S; each of R a , R b , R c , and R d independently represents hydrogen, halogen, C 1 -C 10 alkyl, —OH, —CF 3 , aryl, amino, or nitro; and Ar is optionally substituted with one or more substituents independently selected from the group consisting of halogen, C 1 -C 10 alkyl, —OH, —CF 3 , amino, and nitro. Also provided are pharmaceutical compositions comprising compounds of the invention and a pharmaceutical carrier. Also provided are methods of inhibiting PIP3-mediated signaling in a cell and treating cancer using compounds of the invention.
  • US9701646B2
    申请人:——
    公开号:US9701646B2
    公开(公告)日:2017-07-11
查看更多